Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear

Journal of Lower Genital Tract Disease

Volumn 7, Issue 4, 2003, Pages 294-298

  Ferris, Daron G ^a   Dickman, Eileen D ^a   Litaker, Mark S ^a   Smith, Kelly M ^a   Allmond, Lynn M ^a   Arrington, Terry L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cervical neoplasia; Fluorescent and reflective spectroscopy; Patient acceptance

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER TEST; CHI SQUARE TEST; CLINICAL TRIAL; COLPOSCOPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENT AND REFLECTIVE SPECTROSCOPY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT SATISFACTION; QUESTIONNAIRE; RANK SUM TEST; SPECTROSCOPY; TIME; UTERINE CERVIX CANCER;

EID: 0242320549     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200310000-00012     Document Type: Article

References (9)

1. Burke L, Modell M, Niloff J, Kobelin M, Abu-Jawdeh G, Zelenchuk A. Identification of squamous intraepithelial lesions: Fluorescence of cervical tissue during colposcopy. J Lower Gen Tract Dis 1999;3:159-62.
2. Parker MF, Mooradian GC, Karins JP, O'Connor DM, Speer BA, Owensby PD, et al. Hyperspectral diagnostic imaging of the cervix: Report on a new investigational device. J Lower Gen Tract Dis 2000;4:119-24.
3. Ferris DG, Lawhead RA, Dickman ED, Holtzapple N, Miller JA, Grogan S, et al. Multimodal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia. J Lower Gen Tract Dis 2001;5:65-72.
4. Mitchell MF, Cantor SB, Ramanujam N, Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999;93:462-70.
5. Melnikov J, Kuppermann M, Birch S, Chan BKS, Nuovo J. Management of the low-grade abnormal Pap smear: What are women's preferences? J Fam Pract 2002;51:849-55.
6. Ferris DG, Kriegel D, Cole L, Litaker M, Woodward L. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Arch Fam Med 1997;6:348-53.
7. Agency for Health Care Policy and Research. Evidence Report/Technology Assessment no. 5: Evaluation of Cervical Cytology. Rockville, MD: Agency for Health Care Policy and Research; 1999. US Department of Health and Human Services AHCPR publication no. 99-E010.
8. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
9. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.